Medical Aniracetam Brain Enhancing And Cognition Enhancer Drugs CAS
|Appearance||White crystalline powder|
|Melting point||119°C ~122°C|
|Loss on drying||<0.5%|
|Product Categories:||Brain health drug;Nootropic;Heterocycles;Intermediates & Fine
Aniracetam is a fat-soluble molecule in the racetams family,
anecdotally touted to be more potent than Piracetam and more
catered to creativity and holistic thinking as well as reducing
anxiety and depression.
Aniracetam is a compound in the group of racetams due to its common
pyrrolidone structure. It is one of the more common Racetamic
structures. It is fat-soluble and thus needs to be ingested with
fatty acids. Additionally, Aniracetam is cholinergic.
Aniracetam acts as a positive modulator of some excitatory
receptors known as AMPA receptors and decreases the rate of
receptor desensitization. This typically manifests as a controlled
and prolonged neurological stimulation effect. Since AMPA receptors
differ in structure across the brain, different AMPA modulators
affect the brain in different ways.
Anecdotally, Aniracetam has been know to aid in 'collective and
holistic thinking', or putting the pieces of the puzzle together.
It also increases blood flow and activity in the area of the brain
known for this action, the association cortex.
Aniracetam, as an AMPA modulator, is currently being studied for
usage in depression and other CNS disorders such as Alzheimer's
Things to Note
Aniracetam is known anecdotally to be stimulatory, however it's
effects are unlikecaffeine stimulation.
Aniracetam is fat-soluble, however it appears to be taken up even
in a fasted state. Food does not appear to be needed.
Aniracetam has a highly bitter taste to the powder
Do NOT use Aniracetam if:
- you are allergic to any ingredient in levetiracetam
Contact your doctor or health care provider right away if any of
these apply to you.
Before using levetiracetam:
Some medical conditions may interact with levetiracetam. Tell your
doctor or pharmacist if you have any medical conditions, especially
if any of the following apply to you:
- if you are pregnant, planning to become pregnant, or are
- if you are taking any prescription or nonprescription medicine,
herbal preparation, or dietary supplement
- if you have allergies to medicines, foods, or other substances
- if you have kidney problems or you are on dialysis
- if you have a history of mental or mood problems (eg, depression),
or suicidal thoughts or actions
How to Take Aniracetam?
Recommended dosage, active amounts, other details
Doses between 10 mg bodyweight and 100 mg bodyweight have been used in rats with efficacy in laboratory
settings. Limited human evidence finds that oral doses in the
1,000-1,500 mg range (over the course of a day) tend to be
Doses as low as 400 mg have been reported to have some efficacy,
and it is common to take the above 1,000-1,500 mg aniracetam in two
divided doses of 500-750 mg twice daily with meals.
Aniracetam powder has a highly bitter taste, so capsules may be a
better purchase for those who wish to avoid that.
Memory and Learning
Aniracetam has been found to specifically decrease the rate of
receptor desensitization in lab animal hippocampus (specifically
quisqualate receptors), suggesting a potential benefit to memory
formation. It does not seem affect choline uptake into hippocampal
cells in any way, and actually encourages acetylcholine release.
Aniracetam also increases the release of dopamine and serotonin via
cholinergic mechanisms in the prefrontal cortex. with implications in
improving judgement. This may also in part explain it's involvement
as an anti-depressant. Via either the same or alternate mechanisms
(positive AMPA modulation) Aniracetam has also been shown to reduce
impulsiveness in the rat.
Through the general mechanism of AMPA modulation (and thus
applicable to Piracetam and Oxiracetam), Ampakines can upregulate Brain-derived
Neurotrophic factor (BDNF) for periods longer than the Ampakine's
AUC due to a long BDNF half-life. These effects may be free of
downregulation given some time away from the ampakine's existence
in serum exists. BDNF is implicated in increasing adult neural
|NSI-189/NSI-189 phosphate||cas 1270138-40-3|
|Beta nicotinamide mononucletide|